Cosmetic cross-reference Noindex: medium evidence

Croscarmellose sodium

CAS 74811-65-7

Croscarmellose sodium (CAS 74811-65-7) is a pharmaceutical compound with 0 bioactivity targets and 172 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral / FAERS

Adverse signals

172

SOURCE IUPHAR / PharmGKB

PubMed IDs

0

SOURCE EPA DSSTox

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Croscarmellose sodium

CAS Number

74811-65-7

Source Match

EPA DSSTox

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE DSSTox identifiers DTXSID801016674

Cross-Reference to Chemicals

Same-CAS substance identity is available in the industrial chemicals vertical.

Croscarmellose sodium is linked to DTXSID801016674 in DSSTox identifiers.

View industrial chemical data →

SOURCE RxNorm drug names 5 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
CROSCARMELLOSE SODIUM	1310573	SU	MTHSPL
Croscarmellose Sodium	1310573	SU	MTHSPL
Croscarmellose sodium	1310573	SU	MTHSPL
croscarmellose sodium	1310573	SU	MTHSPL
croscarmellose sodium	1310573	PIN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Croscarmellose sodium used for in pharmaceutical contexts?

Croscarmellose sodium (CAS 74811-65-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Croscarmellose sodium?

Croscarmellose sodium has 172 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Antineutrophil cytoplasmic antibody positive, Anxiety, Arteriosclerosis, Arteriosclerosis coronary artery, Asthma. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Croscarmellose sodium also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Croscarmellose with EU status "permitted".

What clinical phase is Croscarmellose sodium in?

No phase 1-4 clinical development badge is rendered for Croscarmellose sodium because the matched compound identifier rows do not contain a max-phase value.